{
    "nctId": "NCT03663387",
    "title": "PET Measures of CSF Clearance in Preclinical Alzheimer's Disease",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Male and female subjects between 20-100 years old will be enrolled"
                    },
                    {
                        "type": "variable",
                        "value": "All subjects will speak English as their first language or demonstrate proficiency in English"
                    },
                    {
                        "type": "variable",
                        "value": "All subjects may have normal cognition or cognitive impairment"
                    },
                    {
                        "type": "variable",
                        "value": "All subjects will be in good general health and able to participate in the LP and imaging exams"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 20 Years"
                    },
                    {
                        "type": "variable",
                        "value": "Must have maximum age of 100 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Uncontrolled hypertension or metabolic disease"
                            },
                            {
                                "type": "variable",
                                "value": "Neurodegenerative disorders (i.e. Parkinson disease, LBD, or FTD)"
                            },
                            {
                                "type": "variable",
                                "value": "Long life major depression. Baseline scores \u226520 on Beck Depression Inventory at baseline"
                            },
                            {
                                "type": "variable",
                                "value": "Long-life DSM-IV axis 1 disorders"
                            },
                            {
                                "type": "variable",
                                "value": "Mental retardation"
                            },
                            {
                                "type": "variable",
                                "value": "Substance abuse"
                            },
                            {
                                "type": "variable",
                                "value": "Concurrent medication limiting validity of neuropsychological tests or imaging"
                            },
                            {
                                "type": "variable",
                                "value": "Anti-depressants with anti-cholinergic properties"
                            },
                            {
                                "type": "variable",
                                "value": "Monoamine oxidase inhibitors (MAOi)"
                            },
                            {
                                "type": "variable",
                                "value": "Regular use of narcotic analgesics (>2 doses per week)"
                            },
                            {
                                "type": "variable",
                                "value": "Use of neuroleptics"
                            },
                            {
                                "type": "variable",
                                "value": "Implanted medical devices that are incompatible with MRI imaging"
                            },
                            {
                                "type": "variable",
                                "value": "Radiation exposures exceeding annual Rad Worker limits"
                            },
                            {
                                "type": "variable",
                                "value": "Heart failure stage D as defined by American Heart Association"
                            },
                            {
                                "type": "variable",
                                "value": "Chronic kidney disease in stages \u2265 4, as defined per National Kidney Foundation"
                            },
                            {
                                "type": "variable",
                                "value": "Brain tumor and other neoplastic disorders outside the brain where disease itself or its treatment (radiation, chemotherapy) is likely to affect brain structure or function"
                            },
                            {
                                "type": "variable",
                                "value": "Stroke when meeting criteria for total anterior, partial anterior or posterior circulation infarct according to the Oxford Community Stroke Project classification"
                            },
                            {
                                "type": "variable",
                                "value": "Significant head trauma"
                            },
                            {
                                "type": "variable",
                                "value": "Hydrocephalus"
                            },
                            {
                                "type": "variable",
                                "value": "Hostility or refusal to cooperate"
                            },
                            {
                                "type": "variable",
                                "value": "Person's receiving chronic anti-coagulation therapy"
                            },
                            {
                                "type": "variable",
                                "value": "Person's participating in other research projects will be excluded when the other project(s) involve radiation exposure which in combination with the current project would increase radiation exposure above federal guidelines"
                            },
                            {
                                "type": "variable",
                                "value": "Person's participating in other research projects will be excluded when the other project(s) involve administration of study drug or other experimental therapy"
                            },
                            {
                                "type": "variable",
                                "value": "Person's participating in other research projects will be excluded when the other project(s) prohibit participation in other research projects"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('All subjects may have normal cognition or cognitive impairment'), Symbol('All subjects will be in good general health and able to participate in the LP and imaging exams'), Symbol('All subjects will speak English as their first language or demonstrate proficiency in English'), Symbol('Male and female subjects between 20-100 years old will be enrolled'), Symbol('Must have maximum age of 100 Years'), Symbol('Must have minimum age of 20 Years'), Not(Or(Symbol('Anti-depressants with anti-cholinergic properties'), Symbol('Brain tumor and other neoplastic disorders outside the brain where disease itself or its treatment (radiation, chemotherapy) is likely to affect brain structure or function'), Symbol('Chronic kidney disease in stages \u2265 4, as defined per National Kidney Foundation'), Symbol('Concurrent medication limiting validity of neuropsychological tests or imaging'), Symbol('Heart failure stage D as defined by American Heart Association'), Symbol('Hostility or refusal to cooperate'), Symbol('Hydrocephalus'), Symbol('Implanted medical devices that are incompatible with MRI imaging'), Symbol('Long life major depression. Baseline scores \u226520 on Beck Depression Inventory at baseline'), Symbol('Long-life DSM-IV axis 1 disorders'), Symbol('Mental retardation'), Symbol('Monoamine oxidase inhibitors (MAOi)'), Symbol('Neurodegenerative disorders (i.e. Parkinson disease, LBD, or FTD)'), Symbol(\"Person's participating in other research projects will be excluded when the other project(s) involve administration of study drug or other experimental therapy\"), Symbol(\"Person's participating in other research projects will be excluded when the other project(s) involve radiation exposure which in combination with the current project would increase radiation exposure above federal guidelines\"), Symbol(\"Person's participating in other research projects will be excluded when the other project(s) prohibit participation in other research projects\"), Symbol(\"Person's receiving chronic anti-coagulation therapy\"), Symbol('Radiation exposures exceeding annual Rad Worker limits'), Symbol('Regular use of narcotic analgesics (>2 doses per week)'), Symbol('Significant head trauma'), Symbol('Stroke when meeting criteria for total anterior, partial anterior or posterior circulation infarct according to the Oxford Community Stroke Project classification'), Symbol('Substance abuse'), Symbol('Uncontrolled hypertension or metabolic disease'), Symbol('Use of neuroleptics'))))"
}